Outcomes after cryoballoon ablation of paroxysmal atrial fibrillation with the PolarX or the Arctic Front Advance Pro: a prospective multicentre experience
International audience The aim of this study was to compare procedural efficacy and safety, including 1-year freedom from AF recurrence, between the novel cryoballoon system PolarX (Boston Scientific) and the Arctic Front Advance Pro (AFA-Pro) (Medtronic), in patients with paroxysmal AF undergoing P...
Published in: | EP Europace |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Other Authors: | , , , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
HAL CCSD
2023
|
Subjects: | |
Online Access: | https://hal.science/hal-04286975 https://hal.science/hal-04286975/document https://hal.science/hal-04286975/file/euad005.pdf https://doi.org/10.1093/europace/euad005 |